Fadi Haddad, MD

Articles by Fadi Haddad, MD

Lymphatic Mapping in the Treatment of Breast Cancer

ByCharles E. Cox, MS, FACS,Fadi Haddad, MD,Siddarth Bass, MD,John M. Cox, MD,Ni Ni Ku, MD,Claudia Berman, MD,Alan R. Shons, MD, PhD,Timothy Yeatman, MD,Solange Pendas, MD,Douglas S. Reintgen, MD

September 1st 1998

Developed initially for the treatment of malignant melanoma, lymphatic mapping and sentinel lymph node biopsy have recently been introduced into the treatment of early breast cancer. In breast cancer patients, harvested

Latest Updated Articles

Lymphatic Mapping in the Treatment of Breast Cancer
Published: September 1st 1998 | Updated:

Fadi Haddad, MD

Articles by Fadi Haddad, MD

Lymphatic Mapping in the Treatment of Breast Cancer

Latest Updated Articles

Trending on CancerNetwork

FDA OKs Subcutaneous Amivantamab in EGFR+ NSCLC

Imlunestrant Combo Will Not Be Pursued for FDA Approval in Breast Cancer

FDA Grants Regular Approval to Rucaparib in Metastatic CRPC

Gathering Data to Ascertain Biomarker Specificity in HER2– Breast Cancer

Enfortumab Vedotin Combo Improves Survival in Cisplatin-Eligible MIBC